Greta Hultqvist

Title: Greta Hultqvist: Innovator in Brain Delivery Proteins

Introduction

Greta Hultqvist is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of neuroscience through her innovative work on brain delivery proteins. Her research focuses on developing therapeutic solutions for neurodegenerative disorders and other brain diseases.

Latest Patents

Greta Hultqvist holds a patent for a brain delivery protein. This invention comprises a target binding antibody that binds to a target in a mammalian brain. It includes two carrier moieties, each capable of monovalent interaction with a protein expressed on a blood-brain barrier (BBB) endothelial cell. Each carrier moiety is linked to the C-terminal end of the target binding antibody. The invention also relates to the use of such brain delivery proteins in therapy, diagnosis, or research of neurodegenerative disorders and other brain diseases. She has 1 patent to her name.

Career Highlights

Greta Hultqvist is associated with Bioarctic AB, a company dedicated to developing innovative treatments for neurodegenerative diseases. Her work at Bioarctic has positioned her as a key player in the field of brain research and therapy.

Collaborations

Greta collaborates with notable colleagues, including Lars Lannfelt and Stina Syvänen. Their combined expertise enhances the research and development efforts at Bioarctic AB.

Conclusion

Greta Hultqvist's contributions to the field of brain delivery proteins exemplify her commitment to advancing medical science. Her innovative work holds promise for improving therapies for neurodegenerative disorders and other brain diseases.